Clinical Prediction of Glycolysis-Driven Molecular Subclass of Hepatocellular Carcinoma without Transcriptomic Profiling.

Liver Cancer · 2026 · PMC13143330 · PMID 42095119

Europe PMC DOI

hedged sentences

0.0790

closest p · 1.6× alpha

0.0790

boldest claim

The sentences

did not reach statistical significancep = 0.079so close (0.05 < p ≤ 0.1)

Kaplan-Meier survival analysis demonstrated a trend toward shorter OS in the glycolysis subclass compared to the rich metabolism subclass, although the difference did not reach statistical significance ( Fig. 3 a, p = 0.079).

also in 111,027 other papers

showed a trendp = 0.079so close (0.05 < p ≤ 0.1)

Patients classified as the glycolysis subclass showed a trend toward shorter overall survival (median 95 months, p = 0.079) and significantly shorter recurrence-free survival (median 14.4 vs. 37.7 months, p = 0.017).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.